Brimonidine Tartrate contains not less than 99.0% and not more than 101.0% of C11H10BrN5‧C4H6O6, calculated on dried substance.

共有 1 個藥物證書使用此成份

溴摩尼啶酒石酸
Brimonidine Tartrate

• 申請商: 新雙隆生技股份有限公司
• 適應症: 開放角隅青光眼或高眼壓
• 發證日期: 2019-05-09